490 related articles for article (PubMed ID: 14515202)
1. Current strategies and future directions of antiangiogenic tumor therapy.
Zhang ZL; Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
[TBL] [Abstract][Full Text] [Related]
2. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
3. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of the tumor vasculature.
Tozer GM; Bicknell R
Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
[TBL] [Abstract][Full Text] [Related]
5. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
6. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
Gagne P; Akalu A; Brooks PC
Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic gene therapy in inhibition of metastasis.
Szala S; Szary J; Cichoń T; Sochanik A
Acta Biochim Pol; 2002; 49(2):313-21. PubMed ID: 12362972
[TBL] [Abstract][Full Text] [Related]
8. Progress in antiangiogenic gene therapy of cancer.
Feldman AL; Libutti SK
Cancer; 2000 Sep; 89(6):1181-94. PubMed ID: 11002212
[TBL] [Abstract][Full Text] [Related]
9. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
Dutour A; Rigaud M
Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenics and radiotherapy.
Shannon AM; Williams KJ
J Pharm Pharmacol; 2008 Aug; 60(8):1029-36. PubMed ID: 18644195
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy.
Shaked Y; Kerbel RS
Cancer Res; 2007 Aug; 67(15):7055-8. PubMed ID: 17671170
[TBL] [Abstract][Full Text] [Related]
13. Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway.
Ribatti D
Cancer Treat Rev; 2011 Aug; 37(5):344-52. PubMed ID: 21435792
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic cancer therapy.
Cao Y
Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
Oklu R; Walker TG; Wicky S; Hesketh R
J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
[TBL] [Abstract][Full Text] [Related]
16. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
18. A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo.
Ciafrè SA; Barillari G; Bongiorno-Borbone L; Wannenes F; Izquierdo M; Farace MG
Gene Ther; 2002 Feb; 9(4):297-302. PubMed ID: 11896469
[TBL] [Abstract][Full Text] [Related]
19. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy.
Glade Bender J; Cooney EM; Kandel JJ; Yamashiro DJ
Drug Resist Updat; 2004; 7(4-5):289-300. PubMed ID: 15533766
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic strategies for cancer therapy (Review).
Benouchan M; Colombo BM
Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
